ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
7 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
10K
|
5.0M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
prismen
|
1.2K |
645K |
4 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
1.2K
|
645K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Angelman trial
|
|
prismen
|
59 |
30K |
9 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
59
|
30K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
1 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
5.0M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
21 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
5.0M
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
10K
|
5.0M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
prismen
|
187 |
77K |
34 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
187
|
77K
|
34
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
prismen
|
187 |
77K |
17 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
187
|
77K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
prismen
|
187 |
77K |
6 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
187
|
77K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
prismen
|
187 |
77K |
14 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
187
|
77K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Pipeline-in-a-drug
|
|
prismen
|
187 |
77K |
17 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
187
|
77K
|
17
|
|
ASX - By Stock
|
NEU Tax & Taxation |
Re:
Capital gains tax
|
|
prismen
|
24 |
12K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
24
|
12K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
prismen
|
76 |
34K |
38 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
76
|
34K
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
prismen
|
160 |
83K |
24 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
83K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
prismen
|
160 |
83K |
15 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
83K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
10K
|
5.0M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
38 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
10K
|
5.0M
|
38
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
11 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
10K
|
5.0M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
5 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
10K
|
5.0M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
19 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
676
|
314K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
prismen
|
194 |
80K |
9 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
80K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Notification of cessation of securities - NEU
|
|
prismen
|
2 |
1.4K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
2
|
1.4K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
prismen
|
194 |
80K |
25 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
194
|
80K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
prismen
|
194 |
80K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
194
|
80K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
prismen
|
194 |
80K |
24 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
194
|
80K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
26 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
32 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
32
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
26 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
26
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
3 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
9 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
676
|
314K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
676
|
314K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Results webinar
|
|
prismen
|
130 |
65K |
4 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
130
|
65K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
prismen
|
79 |
38K |
11 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
prismen
|
79 |
38K |
27 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
prismen
|
79 |
38K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
prismen
|
79 |
38K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
prismen
|
79 |
38K |
19 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
19 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
676
|
314K
|
19
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
676
|
314K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
prismen
|
676 |
314K |
13 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
676
|
314K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
19 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
10K
|
5.0M
|
19
|
|
Charts
|
NEU |
Re:
Positive Reports
|
|
prismen
|
41 |
18K |
7 |
22/02/24 |
22/02/24 |
Charts
|
41
|
18K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
prismen
|
316 |
167K |
14 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
316
|
167K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
prismen
|
316 |
167K |
55 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
316
|
167K
|
55
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
prismen
|
10K |
5.0M |
9 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
10K
|
5.0M
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
prismen
|
1.2K |
645K |
13 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
1.2K
|
645K
|
13
|
|